Home
About
Overview
Sharing Data
ORCID
Help
History (1)
CT Perfusion as an Early Biomarker of Treatment Efficacy in Advanced Ovarian Cancer: An ACRIN and GOG Study.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
CT Perfusion as an Early Biomarker of Treatment Efficacy in Advanced Ovarian Cancer: An ACRIN and GOG Study.
CT Perfusion as an Early Biomarker of Treatment Efficacy in Advanced Ovarian Cancer: An ACRIN and GOG Study. Clin Cancer Res. 2017 Jul 15; 23(14):3684-3691.
View in:
PubMed
subject areas
Adult
Adult
Aged
Aged
Biomarkers, Tumor
Biomarkers, Tumor
Carboplatin
Carboplatin
Contrast Media
Contrast Media
Diagnostic Imaging
Diagnostic Imaging
Disease-Free Survival
Disease-Free Survival
Dose-Response Relationship, Drug
Dose-Response Relationship, Drug
Female
Female
Humans
Humans
Middle Aged
Middle Aged
Neoplasm Staging
Neoplasm Staging
Ovarian Neoplasms
Ovarian Neoplasms
Paclitaxel
Paclitaxel
Prognosis
Prognosis
Tomography, X-Ray Computed
Tomography, X-Ray Computed
authors with profiles
Joan L Walker
Robert S Mannel